Your browser doesn't support javascript.
loading
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review.
Stolbrink, Marie; Thomson, Helen; Hadfield, Ruth M; Ozoh, Obianuju B; Nantanda, Rebecca; Jayasooriya, Shamanthi; Allwood, Brian; Halpin, David M G; Salvi, Sundeep; de Oca, Maria Montes; Mortimer, Kevin; Rylance, Sarah.
Afiliación
  • Stolbrink M; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK; Division of Pulmonology, Department of Medicine, Stellenbosch University, Cape Town, South Africa. Electronic address: mstolbrink@doctors.org.uk.
  • Thomson H; King's College Hospital, London, UK.
  • Hadfield RM; Australian Institute of Health Innovation, Macquarie University, Sydney, NSW, Australia; Global Initiative for Chronic Obstructive Lung Disease, Deer Park, IL, USA.
  • Ozoh OB; Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.
  • Nantanda R; Makerere University Lung Institute, College of Health Sciences Kampala, Kampala, Uganda.
  • Jayasooriya S; British Thoracic Society Global Health Group, London, UK; University of Sheffield, Sheffield, UK.
  • Allwood B; Division of Pulmonology, Department of Medicine, Stellenbosch University, Cape Town, South Africa; Tygerberg Hospital, Cape Town, South Africa.
  • Halpin DMG; Global Initiative for Chronic Obstructive Lung Disease, Deer Park, IL, USA; University of Exeter Medical School, Exeter, UK.
  • Salvi S; Global Initiative for Chronic Obstructive Lung Disease, Deer Park, IL, USA; Pulmocare Research and Education (PURE) Foundation, Pune, India.
  • de Oca MM; Global Initiative for Chronic Obstructive Lung Disease, Deer Park, IL, USA; Universidad Central de Venezuela, Caracas, Venezuela; Centro Medico de Caracas Hospital, Caracas, Venezuela.
  • Mortimer K; The International Union Against Tuberculosis and Lung Disease, Paris, France; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Rylance S; Noncommunicable Disease Management Unit, WHO, Geneva, Switzerland.
Lancet Glob Health ; 10(10): e1423-e1442, 2022 10.
Article en En | MEDLINE | ID: mdl-36113528
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Medicamentos Esenciales / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspecto: Determinantes_sociais_saude Límite: Humans Idioma: En Revista: Lancet Glob Health Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Medicamentos Esenciales / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspecto: Determinantes_sociais_saude Límite: Humans Idioma: En Revista: Lancet Glob Health Año: 2022 Tipo del documento: Article